Movement Alert｜Hyperliquid Strategies Inc Falls 8.18% in Regular Trading, Profit-Taking After 19% Post-Earnings Surge Amid Broad Sector Weakness

Market Focus

Aug 29

On August 29, Hyperliquid Strategies Inc declined 8.18% in regular trading, trading at $11.785/share, with turnover of $359 million. The pullback follows a sharp 19% rally the prior session after the company reported fiscal 2026 net income of $305.5 million, massively beating FactSet consensus expectations of a $168.3 million net loss.

The retracement comes amid broad weakness in the Biotechnology sector. Among peers, Revolution Medicines fell 6.22%, Moderna dropped 3.96%, Amgen declined 1.28%, AbbVie fell 0.93%, and Alnylam Pharmaceuticals slid 0.43%. Despite the intraday pullback, Hyperliquid Strategies retains significant gains from recent catalysts including the earnings beat, its June inclusion in the Russell 3000 and Russell 2000 indices, and Duquesne's disclosed $23 million position in PURR shares.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/news/1134928181"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1134928181\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1134928181?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-29 02:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134928181","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Hyperliquid Strategies Inc Falls 8.18% in Regular Trading, Profit-Taking After 19% Post-Earnings Surge Amid Broad Sector Weakness","media":"Market Focus","content":"<p><p>On August 29, Hyperliquid Strategies Inc declined 8.18% in regular trading, trading at $11.785/share, with turnover of $359 million. The pullback follows a sharp 19% rally the prior session after the company reported fiscal 2026 net income of $305.5 million, massively beating FactSet consensus expectations of a $168.3 million net loss.</p><p>The retracement comes amid broad weakness in the Biotechnology sector. Among peers, Revolution Medicines fell 6.22%, Moderna dropped 3.96%, Amgen declined 1.28%, AbbVie fell 0.93%, and Alnylam Pharmaceuticals slid 0.43%. Despite the intraday pullback, Hyperliquid Strategies retains significant gains from recent catalysts including the earnings beat, its June inclusion in the Russell 3000 and Russell 2000 indices, and Duquesne's disclosed $23 million position in PURR shares.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Hyperliquid Strategies Inc Falls 8.18% in Regular Trading, Profit-Taking After 19% Post-Earnings Surge Amid Broad Sector Weakness</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Hyperliquid Strategies Inc Falls 8.18% in Regular Trading, Profit-Taking After 19% Post-Earnings Surge Amid Broad Sector Weakness\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-29 02:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 29, Hyperliquid Strategies Inc declined 8.18% in regular trading, trading at $11.785/share, with turnover of $359 million. The pullback follows a sharp 19% rally the prior session after the company reported fiscal 2026 net income of $305.5 million, massively beating FactSet consensus expectations of a $168.3 million net loss.</p><p>The retracement comes amid broad weakness in the Biotechnology sector. Among peers, Revolution Medicines fell 6.22%, Moderna dropped 3.96%, Amgen declined 1.28%, AbbVie fell 0.93%, and Alnylam Pharmaceuticals slid 0.43%. Despite the intraday pullback, Hyperliquid Strategies retains significant gains from recent catalysts including the earnings beat, its June inclusion in the Russell 3000 and Russell 2000 indices, and Duquesne's disclosed $23 million position in PURR shares.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PURR","symbol_name":"Hyperliquid Strategies Inc","start_time":0,"source_url":"","article_id":"1134928181","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134928181","pubTimestamp":1787942092,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 29, Hyperliquid Strategies Inc declined 8.18% in regular trading, trading at $11.785/share, with turnover of $359 million. The pullback follows a sharp 19% rally the prior session after the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PURR":"Hyperliquid Strategies Inc"},"translate_title":"走势警报|Hyperliquid Strategies Inc 在常规交易中下跌 8.18%，在整体行业疲软的情况下盈利后飙升 19% 后获利了结","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PURR":1},"content_text":"On August 29, Hyperliquid Strategies Inc declined 8.18% in regular trading, trading at $11.785/share, with turnover of $359 million. The pullback follows a sharp 19% rally the prior session after the company reported fiscal 2026 net income of $305.5 million, massively beating FactSet consensus expectations of a $168.3 million net loss.The retracement comes amid broad weakness in the Biotechnology sector. Among peers, Revolution Medicines fell 6.22%, Moderna dropped 3.96%, Amgen declined 1.28%, AbbVie fell 0.93%, and Alnylam Pharmaceuticals slid 0.43%. Despite the intraday pullback, Hyperliquid Strategies retains significant gains from recent catalysts including the earnings beat, its June inclusion in the Russell 3000 and Russell 2000 indices, and Duquesne's disclosed $23 million position in PURR shares.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}